BioAtla, Inc. (BCAB) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Bioatla, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.799 Good day, everyone, and welcome to today's BioATLA first quarter 2025 00:00:05.799 -- 00:00:11.587 earnings call. At this time, all participants are in a listen-only mode. 00:00:11.587 -- 00:00:16.855 Later, you will have the opportunity to ask questions during the question and answer 00:00:16.855 -- 00:00:18.397 session. 00:00:18.397 -- 00:00:21.762 I will be standing by should you need any assistance. 00:00:21.762 -- 00:00:26.809 It is now my pleasure to turn the conference over to Bruce Mackle with LifeSci 00:00:26.809 -- 00:00:30.271 Advisors. Please go ahead. 00:00:30.271 -- 00:00:33.276 Thank you, Operator, and good afternoon, everyone. 00:00:33.276 -- 00:00:36.500 With me today on the phone from BioATLA are Dr. 00:00:36.500 -- 00:00:42.269 Jay Short, Chairman, CEO, and Co-Founder, and Richard Waldron, 00:00:42.269 -- 00:00:44.813 Chief Financial Officer. 00:00:44.813 -- 00:00:49.941 Following today's call, Dr. Eric Seavers, Chief Medical Officer, and 00:00:49.941 -- 00:00:54.969 Sherry Lydick, Chief Commercial Officer, will join Jay and Rick in a 00:00:54.969 -- 00:00:57.254 short Q&A. 00:00:57.254 -- 00:01:02.102 Earlier this afternoon, BioAtla released financial results and a business update for 00:01:02.102 -- 00:01:06.929 the first quarter ended March 31, 2025. A 00:01:06.929 -- 00:01:13.800 copy of the press release and corporate presentation are available on the company's website. 00:01:13.800 -- 00:01:19.008 Before we begin, I'd like to remind everyone that statements made during this conference 00:01:19.008 -- 00:01:24.177 call will include forward-looking statements, including, but not 00:01:24.177 -- 00:01:29.831 limited to, statements regarding BioAtlas business plans and prospects, 00:01:29.831 -- 00:01:34.196 an...